CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin

Journal of Pharmacological Sciences

Volumn 124, Issue 4, 2014, Pages 486-493

  Liu, Xuejiao ^a   Niu, Mingshan ^a   Xu, Xiaoyu ^a   Cai, Wei ^a   Zeng, Lingyu ^a   Zhou, Xiuping ^a   Yu, Rutong ^a   Xu, Kailin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor; CRM1; Nuclear protein export; Plumbagin

Indexed keywords

EXPORTIN 1; PLUMBAGIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; MASS SPECTROMETRY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

CELL LINE, TUMOR; CELL NUCLEUS; DRUG DESIGN; HUMANS; KARYOPHERINS; MOLECULAR TARGETED THERAPY; NAPHTHOQUINONES; NEOPLASMS; NUCLEAR PROTEINS; PHYTOTHERAPY; PLUMBAGINACEAE; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TUMOR SUPPRESSOR PROTEINS;

EID: 84899564747     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13240FP     Document Type: Article

References (27)

1. Marczak Ł, Kawiak A, Łojkowska E, Stobiecki M. Secondary metabolites in in vitro cultured plants of the genus Drosera. Phytochem Anal. 2005;16:143-149. (Pubitemid 40903217)
2. Dzoyem J, Tangmouo J, Lontsi D, Etoa F, Lohoue P. In vitro antifungal activity of extract and plumbagin from the stem bark of Diospyros crassiflora Hiern (Ebenaceae). Phytother Res. 2007;21:671-674. (Pubitemid 47066784)
3. Luo P, Wong YF, Ge L, Zhang ZF, Liu Y, Liu L, et al. Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-κB activation. J Pharmacol Exp Ther. 2010;335:735-742.
4. Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-κB and Bcl-2. J Cell Biochem. 2008;105: 1461-1471.
5. Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008;68:9024-9032.
6. Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, et al. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013;132:1201-1212.
7. Srinivas P, Gopinath G, Banerji A, Dinakar A, Srinivas G. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol Carcinogen. 2004;40: 201-211. (Pubitemid 39056312)
8. Lai L, Liu J, Zhai D, Lin Q, He L, Dong Y, et al. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Brit J Pharmacol. 2012;165:1084-1096.
9. Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem. 2006;281:17023-17033.
10. Stade K, Ford CS, Guthrie C, Weis K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell. 1997;90:1041-1050. (Pubitemid 27408518)
11. Dong X, Biswas A, Süel KE, Jackson LK, Martinez R, Gu H, et al. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature. 2009;458:1136-1141.
12. Pathria G, Wagner C, Wagner SN. Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways. J Invest Dermatol. 2012;132:2780-2790.
13. Connor MK, Kotchetkov R, Cariou S, Resch A, Lupetti R, Beniston RG, et al. CRM1/Ran-mediated nuclear export of p27Kip1 involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell. 2003;14:201-213. (Pubitemid 36106030)
14. Turner JG, Sullivan DM. CRM1-mediated nuclear export of proteins and drug resistance in cancer. Curr Med Chem. 2008;15:2648-2655.
15. Vigneri P, Wang JY. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med. 2001;7:228-234. (Pubitemid 32148491)
16. Vogt PK, Jiang H, Aoki M. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle. 2005;4:908-913. (Pubitemid 41359756)
17. Wang W, Budhu A, Forgues M, Wang XW. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol. 2005;7:823-830. (Pubitemid 41079055)
18. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A. 1999;96:9112-9117.
19. Xiao K, Jiang J, Guan C, Dong C, Wang G, Bai L, et al. Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J Pharmacol Sci. 2013; 123:102-109.
20. Niu M, Sun Y, Liu X, Tang L, Qiu R. Tautomycetin induces apoptosis by inactivating Akt through a PP1-independent signaling pathway in human breast cancer cells. J Pharmacol Sci. 2013;121:17-24.
21. Mutka SC, Yang WQ, Dong SD, Ward SL, Craig DA, Timmermans PB, et al. Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res. 2009;69: 510-517.
22. Lu H, Huang H. FOXO1: a potential target for human diseases. Curr Drug Targets. 2011;12:1235-1244.
23. Hilliard M, Frohnert C, Spillner C, Marcone S, Nath A, Lampe T, et al. The anti-inflammatory prostaglandin 15-Deoxy-Δ12, 14-PGJ2 inhibits CRM1-dependent nuclear protein export. J Biol Chem. 2010;285:22202-22210.
24. Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev. 2012;32:1131-1158.
25. Newlands E, Rustin G, Brampton M. Phase I trial of elactocin. Brit J Cancer. 1996;74:648.
26. Qiao Q, Jiang Y, Li G. Inhibition of the PI3K/AKT-NF-kappaB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma. J Pharmacol Sci. 2013;121: 247-256.
27. Zanella F, dos Santos NR, Link W. Moving to the core: spatiotemporal analysis of forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation. Traffic. 2013;14:247-258.